146 related articles for article (PubMed ID: 34592152)
1. HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells.
Lu H; Lyu Y; Tran L; Lan J; Xie Y; Yang Y; Murugan NL; Wang YJ; Semenza GL
Cell Rep; 2021 Sep; 36(13):109757. PubMed ID: 34592152
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL
Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.
Zhang C; Samanta D; Lu H; Bullen JW; Zhang H; Chen I; He X; Semenza GL
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2047-56. PubMed ID: 27001847
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy.
Xiang L; Semenza GL
Adv Cancer Res; 2019; 141():175-212. PubMed ID: 30691683
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
7. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.
Semenza GL
Clin Sci (Lond); 2015 Dec; 129(12):1037-45. PubMed ID: 26405042
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α-Mediated Telomerase Reverse Transcriptase Activation Inducing Autophagy Through Mammalian Target of Rapamycin Promotes Papillary Thyroid Carcinoma Progression During Hypoxia Stress.
Song H; Chen X; Jiao Q; Qiu Z; Shen C; Zhang G; Sun Z; Zhang H; Luo QY
Thyroid; 2021 Feb; 31(2):233-246. PubMed ID: 32772829
[No Abstract] [Full Text] [Related]
10. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
Lan J; Wei G; Liu J; Yang F; Sun R; Lu H
Theranostics; 2022; 12(6):2598-2612. PubMed ID: 35401817
[No Abstract] [Full Text] [Related]
11. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
12. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness.
Lu H; Xie Y; Tran L; Lan J; Yang Y; Murugan NL; Wang R; Wang YJ; Semenza GL
J Clin Invest; 2020 Sep; 130(9):4607-4623. PubMed ID: 32427586
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment.
Lan J; Lu H; Samanta D; Salman S; Lu Y; Semenza GL
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9640-E9648. PubMed ID: 30242135
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1α (HIF-1α) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions.
Yi T; Papadopoulos E; Hagner PR; Wagner G
J Biol Chem; 2013 Jun; 288(26):18732-42. PubMed ID: 23667251
[TBL] [Abstract][Full Text] [Related]
17. NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification.
Yang Y; Chen C; Zuo Q; Lu H; Salman S; Lyu Y; Huang TY; Wicks EE; Jackson W; Datan E; Wang R; Wang Y; Le N; Zhu Y; Qin W; Semenza GL
Sci Adv; 2022 Dec; 8(49):eabo5000. PubMed ID: 36490339
[TBL] [Abstract][Full Text] [Related]
18. Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog
Zhang X; Li F; Zheng Y; Wang X; Wang K; Yu Y; Zhao H
Oxid Med Cell Longev; 2019; 2019():9078209. PubMed ID: 30906504
[TBL] [Abstract][Full Text] [Related]
19. FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status.
Moreno-Manzano V; Rodríguez-Jiménez FJ; Aceña-Bonilla JL; Fustero-Lardíes S; Erceg S; Dopazo J; Montaner D; Stojkovic M; Sánchez-Puelles JM
J Biol Chem; 2010 Jan; 285(2):1333-42. PubMed ID: 19897487
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells.
Xiang L; Gilkes DM; Hu H; Luo W; Bullen JW; Liang H; Semenza GL
Oncotarget; 2015 May; 6(14):11768-78. PubMed ID: 26059435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
